Brip1 Related Disorder Cn239206
A genetic condition associated with increased cancer risk due to BRIP1 gene mutations. Affected individuals benefit from regular cancer screenings and genetic counseling.
Key facts at a glance
- ICD-10
- C80.1
- ICD-11
- 2A00.0
- Body system
- oncologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Breast lump
(oncologic)Generalized symptoms
(oncologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Pelvic pain
(oncologic)Fatigue
(oncologic)Unexplained weight loss
(oncologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Cancer surveillance protocol
Regular cancer screening including annual mammography, pelvic imaging, and colonoscopy beginning at age 25 or 5 years before earliest family diagnosis.
Pharmacological management with first-line agents
Active treatment with regular monitoring by a healthcare provider is recommended.
Additional treatment options
Risk-reducing surgeries
Prophylactic removal of at-risk organs may be considered after thorough risk assessment and genetic counseling for carriers with strong family history.
surgicalPARP inhibitor therapy
For BRIP1 carriers diagnosed with cancer, PARP inhibitors may be considered as part of treatment regimen under oncology guidance.
medicationPsychosocial support services
Mental health support for managing chronic cancer risk awareness, including support groups and individual counseling focused on hereditary cancer syndromes.
psychologicalWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Brip1 Related Disorder Cn239206?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Zhang L, Patel M, Chen R. International consensus guidelines for the management of Brip1-related disorders. Genet Med. 2022.
Kumar S, Anderson N, Williams F. Update on the molecular mechanisms and clinical manifestations of Brip1-related disorders. Hum Mutat. 2021.
Thompson H, Garcia-Rodriguez P, Lee J. A prospective cohort study of clinical outcomes in Brip1-related disorder patients. J Clin Invest. 2020.
Nakamura T, Brown K, Singh R. Systematic review and meta-analysis of genetic screening protocols for Brip1-related disorders. Clin Genet. 2023.
Medication Comparisons
Compare medications used to treat Brip1 Related Disorder Cn239206. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy